DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
ROCKET AF Study Investigators.
Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study
Am Heart J 2010; 159 (3) 340-347, e1
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.